Skip to content
healthcare.dev

QAMZOVA

NDC 82972-001, Meloxicam, injection, from Nanjing Delova Biotech Co., Ltd..

Product NDC
82972-001
Status
Listed
Labeler
Nanjing Delova Biotech Co., Ltd.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217593
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82972-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MELOXICAM30 mg/mL

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
82972-001-30829720001301 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/385fd779-1be1-49ae-8213-750b96ecc997

Use it

Look up 82972-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82972-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82972-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.